Prevention of Readmissions at IBD Centres of Excellence

• Register: ClinicalTrials.gov
• Last refreshed on: 12 December 2020
• Main ID: NCT02931799
• Date of registration: 11/10/2016
• Prospective Registration: Yes
• Primary sponsor: Mount Sinai Hospital, Canada
• Public title: Prevention of Readmissions at IBD Centres of Excellence PRICE
• Scientific title: Prevention of Readmissions at Inflammatory Bowel Disease Centres of Excellence
• Date of first enrolment: October 1, 2018
• Target sample size: 400
• Recruitment status: Not yet recruiting
• URL: https://clinicaltrials.gov/show/NCT02931799
• Study type: Interventional
• Study design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Health Services Research. Masking: None (Open Label).
• Phase: N/A

Countries of recruitment

Canada

Contacts

• Name: Geoffrey Nguyen, MD, PhD

• Name: Nguyen Geoffrey, MD, PhD

• Name: Geoffrey Nguyen, MD, PhD
• Affiliation: Mount Sinai Hospital, Canada

Key inclusion & exclusion criteria

Inclusion Criteria:

- At least 18 years of age

- IBD diagnosis of UC or CD

- Hospitalization for diagnosis or exacerbation of IBD

Exclusion Criteria:

- Inability to provide informed consent

- No internet access

- Death during hospitalization

- History of surgical management for IBD



Age minimum: 18 Years
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Colitis, Ulcerative

Crohn Disease

Inflammatory Bowel Diseases

Intervention(s)

Other: Standard of Care

Behavioral: Nurse Follow-Up

Other: Post-Discharge Questionnaire

Other: Electronic Monitoring

Primary Outcome(s)

Post-Discharge Readmission [Time Frame: Within 30 days of initial hospital discharge]

Secondary Outcome(s)

IBD related Quality of Life [Time Frame: 30 days post-discharge]

Post-Discharge Occurrence of Venous Thromboembolism [Time Frame: Within 30 days of initial hospital discharge]

Disease Activity [Time Frame: 30 days post-discharge]

Patient Satisfaction with Health Care in IBD [Time Frame: 30 days post-discharge]

Patient Satisfaction with 'Health Promise' [Time Frame: 30 days post-discharge]

Secondary ID(s)

PRICE

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Crohn's and Colitis Canada